Foster Innovation and Collaboration at the 9th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference!
Join us in June 2025 as our renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.
This year's conference offers an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.
Why Attend?
- Foster Collaboration and Innovation: Engage with industry leaders such as AstraZeneca, Gilead, and Alnylam to explore new opportunities, address challenges like large-volume delivery, and stay informed about emerging technologies.
- Stay Updated on Global Regulatory Trends: Participate in discussions on evolving EU and US regulations, including the latest digital health technology registration requirements, with insights from Merck.
- Optimize Combination Product Manufacturing: Learn strategies from leaders like Ionis to enhance combination product manufacturing and effectively manage product lifecycles.
- Enhance Human Factors Understanding: Gain practical knowledge from JnJ and AbbVie on best practices for human factors, including testing and validation approaches for combination products.
What You'll Gain:
- Actionable insights to strengthen your drug-device portfolio.
- Opportunities to network with key players shaping the injectable drug delivery landscape.
- A future-focused perspective on innovation, regulation, and patient-centric care.
This must-attend event is your chance to stay ahead in the rapidly evolving injectable drug delivery space. We look forward to welcoming you to the West Coast in June 2025!
Featured Speakers
- Alasdair Young, Senior Director - Device Engineering, Gilead Sciences
- Amin Sedighiamiri, Director, Device Development, AstraZeneca
- Aniket Badkar, Director, Pharmaceutical Product Development, Vir Biotechnology
- Bernie Huyghe, Chief Technology Officer, Candid Therapeutics
- Christina Rabolli, Principal Engineer, Device Development, Bristol Myers Squibb
- Confirmed Representative, Gilead Sciences
- Daphne King, Previously Associate Director, Regulatory CMC, Biomarin
- EJ Brandreth, Senior VP, Quality, Inovio
- James P. Wabby, Executive Director, Head of Regulatory Strategy, emerging Technologies and Combination Products, AbbVie
- Kevin Zen, Senior Director, IGM Biosciences
- Kinsuk Shah, Sr. AD Combination Product Steward, Boehringer Ingelheim
- Mitch Zhao, Distinguished Engineer, JnJ Innovative Medicine
- Phil Estepa, Executive Director, Pharmaceutical Development, Ionis Pharmaceuticals
- Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
- Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
- Sheldon Moberg, Senior VP Drug Delivery, Bexson Biomedical
- Shiang Gwee, Director, Drug Product Development, Altrubio, Inc.
- Sujit K. Basu, Vice President & Head, Ionis
- Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals
- Wenjing Wang, Associate Principal Scientist in Regulatory Affairs, Merck & Co
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
San Diego Marriott La Jolla
4240 La Jolla Village Drive,
La Jolla, San Diego, Callifornia, USA